Neoleukin Therapeutics, Inc.
NLTX
NASDAQ Global Market3.49
USD
+0.05
- -
Total Valuation
Neoleukin Therapeutics, Inc. carries a market capitalization of 8.20M, placing it among publicly traded companies globally.
| Market Cap | 8.20M |
| Enterprise Value | N/A |
Stock Price Statistics
Neoleukin Therapeutics, Inc.'s stock has declined approximately -69.38596% over the past 52 weeks. The 50-day moving average sits at 13.83, while the 200-day moving average is 14.98.
| Beta (5Y) | N/A |
| 52-Week Price Change | -69.38596% |
| 50-Day Moving Average | 13.83 |
| 200-Day Moving Average | 14.98 |
| Average Volume (20 Days) | N/A |
Stock Splits
Neoleukin Therapeutics, Inc.'s most recent stock split took place on December 19, 2023 with a 4:1 split ratio.
| Last Split Date | 12/19/2023 |
| Split Ratio | 4:1 |